Radioligand Theranostics
Explore our Radioligand Theranostics, offering precise diagnostics. We utilize leading-edge technology for accurate insights and personalized care.
Precision That’s Changing Cancer Care With Radioligand Therapy
Radioligand Therapy (RLT) combines a cancer-seeking molecule with a therapeutic radioisotope to deliver radiation exactly where it’s needed. This means powerful treatment with minimal damage to healthy tissue.
How does RLT work?
Radioligand Therapy uses two powerful components working in harmony: A targeting ligand and a therapeutic radioisotope.
01. Targeting: The ‘key’ that knows where
This ensures that the therapeutic agent is delivered only to diseased tissues, not healthy ones.
The ligand is designed to seek and bind to receptors that are highly overexpressed in cancer cells.
02. Delivery: Radiation with millimetre accuracy
The ligand carries a radioisotope that emits
short-range therapeutic radiation.
Once attached to the cancer cell, it releases a highly concentrated, cell-killing dose, affecting only the immediate area.
Healthy tissues around it remain largely unaffected.
A dual-action treatment that combines molecular
precision with localised radiation, making it effective for
metastatic, widespread, or difficult-to-access cancers.
Know Your RLT
Radioligand Therapy uses two powerful components working in harmony: A targeting ligand and a therapeutic radioisotope.
01. PSMA Radioligand Therapy (Lu-177 / Ac225 / Tb161 – Pluvicto)
For metastatic prostate cancer showing PSMA uptake on PET.
Safe, effective, and known to improve overall survival and quality of life.
02. Neuroendocrine Tumor Therapies (177Lu / Ac225 / Tb161 Dotatate)
Targets somatostatin receptors in NETs and refractory meningiomas.
Highly specific and widely used for advanced and metastatic NETs.
03. FAPI Therapies (Lu-177 / Ac225 / Tb161)
Targets FAP-expressing cells in the tumor microenvironment.
Used for progressive or metastatic breast, ovary,
lung, head & neck, sarcoma, GI, and GU cancers.
04. Iodine Therapies (I-131)
For Graves’ Disease: Destroys overactive thyroid cells.
For Thyroid Cancer: Eliminates residual or metastatic
thyroid cancer cells post-surgery.
05. MIBG Therapy
For neuroblastoma, pheochromocytoma, and paraganglioma, delivering targeted radiation to sympathetic tissue tumors.
06. Y-90 Therapy
For primary and metastatic liver tumors, offering a localized and effective treatment option.
A dual-action treatment that combines molecular
precision with localised radiation, making it effective for
metastatic, widespread, or difficult-to-access cancers.
What is Lu-177 ?
A radioactive isotope that emits millimetre-range radiation, ensuring treatment stays focused on cancer cells with minimal impact beyond the tumor.
Advancement in medicine brought to you by trusted hands.
Radioligand therapy is one of the most advanced forms of cancer treatment. For further information on how it can help you or your loved ones, please talk to us. Battling cancer can be overwhelming, but Aster stands with you at every step. With highly qualified, compassionate healthcare professionals by your side, you’re always in safe hands.
Various types of Radiogland theranostics
Lu-177 Fapi Therapy
It is an advanced and targeted treatment designed for cancers that are difficult to treat with standard therapies like chemotherapy or radiation.
Lu-177 PSMA Therapy
Lutetium-177 PSMA therapy is a type of targeted radioligand therapy that precisely delivers radiation to prostate cancer cells expressing Prostate-Specific Membrane Antigen.
Lu-177 Dotatate therapy
At our advanced Theranostics center in Bangalore, we provide Lu-177 DOTATATE an FDA-approved therapy for treating advanced and metastatic (GEP-NETs)
Nuclear Oncology
An FDG PET/CT scan is an advanced, non-invasive imaging test that combines two …
Iodine Therapy
An FDG PET/CT scan is an advanced, non-invasive imaging test that combines two …
GPC3 Targeted Therapy
GPC3 (Glypican-3) is a protein highly expressed on many hepatocellular carcinoma (HCC) …
Subsribe To Our Newsletter
Stay in touch with us to get latest news and special offers.